Clinafloxacin versus Piperacillin-Tazobactam in Treatment of Patients with Severe Skin and Soft Tissue Infections

Patients (n = 409) with severe skin and soft tissue infections (SSTIs) were randomized to receive clinafloxacin or piperacillin-tazobactam (plus optional vancomycin for methicillin-resistant cocci), administered intravenously, with the option to switch to oral medication. Most patients had celluliti...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Siami, G., Christou, N., Eiseman, I., Tack, K. J.
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society for Microbiology 2001
Materias:
Clinical Therapeutics
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC90322/
https://ncbi.nlm.nih.gov/pubmed/11158750
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.45.2.525-531.2001
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares